Pharmakologische und toxikologische Aspekte neuer Imidazoacridinon-Antitumorsubstanzen
Gespeichert in:
| 1. Verfasser: | |
|---|---|
| Format: | Abschlussarbeit Buch |
| Sprache: | German |
| Veröffentlicht: |
Aachen
Shaker
1996
|
| Ausgabe: | Als Ms. gedr. |
| Schriftenreihe: | Berichte aus der Chemie
|
| Schlagworte: | |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
MARC
| LEADER | 00000nam a2200000 c 4500 | ||
|---|---|---|---|
| 001 | BV010591509 | ||
| 003 | DE-604 | ||
| 005 | 19960321 | ||
| 007 | t| | ||
| 008 | 960122s1996 gw ad|| m||| 00||| ger d | ||
| 016 | 7 | |a 946557284 |2 DE-101 | |
| 020 | |a 3826511530 |c Pb. : DM 94.00, sfr 99.00, S 659.00 |9 3-8265-1153-0 | ||
| 035 | |a (OCoLC)75699186 | ||
| 035 | |a (DE-599)BVBBV010591509 | ||
| 040 | |a DE-604 |b ger |e rakddb | ||
| 041 | 0 | |a ger | |
| 044 | |a gw |c DE | ||
| 049 | |a DE-355 |a DE-12 |a DE-29T |a DE-11 |a DE-188 | ||
| 084 | |a VS 9107 |0 (DE-625)147725:260 |2 rvk | ||
| 084 | |a XI 7004 |0 (DE-625)153024:12910 |2 rvk | ||
| 100 | 1 | |a Berger, Birgit |e Verfasser |4 aut | |
| 245 | 1 | 0 | |a Pharmakologische und toxikologische Aspekte neuer Imidazoacridinon-Antitumorsubstanzen |c Birgit Berger |
| 250 | |a Als Ms. gedr. | ||
| 264 | 1 | |a Aachen |b Shaker |c 1996 | |
| 300 | |a IV, 189 S. |b Ill., graph. Darst. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 490 | 0 | |a Berichte aus der Chemie | |
| 502 | |a Zugl.: Hamburg, Univ., Diss., 1995 | ||
| 650 | 0 | 7 | |a Proliferation |0 (DE-588)4047461-6 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Krebszelle |0 (DE-588)4128704-6 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Acridinonderivate |0 (DE-588)4141311-8 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Acridinon |0 (DE-588)4141310-6 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Imidazolgruppe |0 (DE-588)4161309-0 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Toxizität |0 (DE-588)4078372-8 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Cytostatikum |0 (DE-588)4068347-3 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Pharmakologie |0 (DE-588)4045687-0 |2 gnd |9 rswk-swf |
| 655 | 7 | |0 (DE-588)4113937-9 |a Hochschulschrift |2 gnd-content | |
| 689 | 0 | 0 | |a Acridinon |0 (DE-588)4141310-6 |D s |
| 689 | 0 | 1 | |a Cytostatikum |0 (DE-588)4068347-3 |D s |
| 689 | 0 | 2 | |a Pharmakologie |0 (DE-588)4045687-0 |D s |
| 689 | 0 | |5 DE-604 | |
| 689 | 1 | 0 | |a Acridinonderivate |0 (DE-588)4141311-8 |D s |
| 689 | 1 | 1 | |a Imidazolgruppe |0 (DE-588)4161309-0 |D s |
| 689 | 1 | 2 | |a Cytostatikum |0 (DE-588)4068347-3 |D s |
| 689 | 1 | |5 DE-604 | |
| 689 | 2 | 0 | |a Acridinonderivate |0 (DE-588)4141311-8 |D s |
| 689 | 2 | 1 | |a Pharmakologie |0 (DE-588)4045687-0 |D s |
| 689 | 2 | |5 DE-604 | |
| 689 | 3 | 0 | |a Acridinonderivate |0 (DE-588)4141311-8 |D s |
| 689 | 3 | 1 | |a Toxizität |0 (DE-588)4078372-8 |D s |
| 689 | 3 | |5 DE-604 | |
| 689 | 4 | 0 | |a Acridinonderivate |0 (DE-588)4141311-8 |D s |
| 689 | 4 | 1 | |a Krebszelle |0 (DE-588)4128704-6 |D s |
| 689 | 4 | 2 | |a Proliferation |0 (DE-588)4047461-6 |D s |
| 689 | 4 | |5 DE-604 | |
| 943 | 1 | |a oai:aleph.bib-bvb.de:BVB01-007063097 | |
Datensatz im Suchindex
| DE-BY-UBR_call_number | 23/V16772 |
|---|---|
| DE-BY-UBR_katkey | 2211522 |
| DE-BY-UBR_location | 00 |
| DE-BY-UBR_media_number | 069019868235 |
| _version_ | 1822756747763253248 |
| any_adam_object | |
| author | Berger, Birgit |
| author_facet | Berger, Birgit |
| author_role | aut |
| author_sort | Berger, Birgit |
| author_variant | b b bb |
| building | Verbundindex |
| bvnumber | BV010591509 |
| classification_rvk | VS 9107 XI 7004 |
| ctrlnum | (OCoLC)75699186 (DE-599)BVBBV010591509 |
| discipline | Chemie / Pharmazie Medizin |
| edition | Als Ms. gedr. |
| format | Thesis Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02464nam a2200661 c 4500</leader><controlfield tag="001">BV010591509</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">19960321 </controlfield><controlfield tag="007">t|</controlfield><controlfield tag="008">960122s1996 gw ad|| m||| 00||| ger d</controlfield><datafield tag="016" ind1="7" ind2=" "><subfield code="a">946557284</subfield><subfield code="2">DE-101</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">3826511530</subfield><subfield code="c">Pb. : DM 94.00, sfr 99.00, S 659.00</subfield><subfield code="9">3-8265-1153-0</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)75699186</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV010591509</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakddb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">ger</subfield></datafield><datafield tag="044" ind1=" " ind2=" "><subfield code="a">gw</subfield><subfield code="c">DE</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-355</subfield><subfield code="a">DE-12</subfield><subfield code="a">DE-29T</subfield><subfield code="a">DE-11</subfield><subfield code="a">DE-188</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">VS 9107</subfield><subfield code="0">(DE-625)147725:260</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">XI 7004</subfield><subfield code="0">(DE-625)153024:12910</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Berger, Birgit</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Pharmakologische und toxikologische Aspekte neuer Imidazoacridinon-Antitumorsubstanzen</subfield><subfield code="c">Birgit Berger</subfield></datafield><datafield tag="250" ind1=" " ind2=" "><subfield code="a">Als Ms. gedr.</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Aachen</subfield><subfield code="b">Shaker</subfield><subfield code="c">1996</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">IV, 189 S.</subfield><subfield code="b">Ill., graph. Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">Berichte aus der Chemie</subfield></datafield><datafield tag="502" ind1=" " ind2=" "><subfield code="a">Zugl.: Hamburg, Univ., Diss., 1995</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Proliferation</subfield><subfield code="0">(DE-588)4047461-6</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Krebszelle</subfield><subfield code="0">(DE-588)4128704-6</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Acridinonderivate</subfield><subfield code="0">(DE-588)4141311-8</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Acridinon</subfield><subfield code="0">(DE-588)4141310-6</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Imidazolgruppe</subfield><subfield code="0">(DE-588)4161309-0</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Toxizität</subfield><subfield code="0">(DE-588)4078372-8</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Cytostatikum</subfield><subfield code="0">(DE-588)4068347-3</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Pharmakologie</subfield><subfield code="0">(DE-588)4045687-0</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)4113937-9</subfield><subfield code="a">Hochschulschrift</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Acridinon</subfield><subfield code="0">(DE-588)4141310-6</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Cytostatikum</subfield><subfield code="0">(DE-588)4068347-3</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="2"><subfield code="a">Pharmakologie</subfield><subfield code="0">(DE-588)4045687-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="1" ind2="0"><subfield code="a">Acridinonderivate</subfield><subfield code="0">(DE-588)4141311-8</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="1"><subfield code="a">Imidazolgruppe</subfield><subfield code="0">(DE-588)4161309-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="2"><subfield code="a">Cytostatikum</subfield><subfield code="0">(DE-588)4068347-3</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="2" ind2="0"><subfield code="a">Acridinonderivate</subfield><subfield code="0">(DE-588)4141311-8</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="2" ind2="1"><subfield code="a">Pharmakologie</subfield><subfield code="0">(DE-588)4045687-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="2" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="3" ind2="0"><subfield code="a">Acridinonderivate</subfield><subfield code="0">(DE-588)4141311-8</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="3" ind2="1"><subfield code="a">Toxizität</subfield><subfield code="0">(DE-588)4078372-8</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="3" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="4" ind2="0"><subfield code="a">Acridinonderivate</subfield><subfield code="0">(DE-588)4141311-8</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="4" ind2="1"><subfield code="a">Krebszelle</subfield><subfield code="0">(DE-588)4128704-6</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="4" ind2="2"><subfield code="a">Proliferation</subfield><subfield code="0">(DE-588)4047461-6</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="4" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="943" ind1="1" ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-007063097</subfield></datafield></record></collection> |
| genre | (DE-588)4113937-9 Hochschulschrift gnd-content |
| genre_facet | Hochschulschrift |
| id | DE-604.BV010591509 |
| illustrated | Illustrated |
| indexdate | 2024-12-23T14:04:51Z |
| institution | BVB |
| isbn | 3826511530 |
| language | German |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-007063097 |
| oclc_num | 75699186 |
| open_access_boolean | |
| owner | DE-355 DE-BY-UBR DE-12 DE-29T DE-11 DE-188 |
| owner_facet | DE-355 DE-BY-UBR DE-12 DE-29T DE-11 DE-188 |
| physical | IV, 189 S. Ill., graph. Darst. |
| publishDate | 1996 |
| publishDateSearch | 1996 |
| publishDateSort | 1996 |
| publisher | Shaker |
| record_format | marc |
| series2 | Berichte aus der Chemie |
| spellingShingle | Berger, Birgit Pharmakologische und toxikologische Aspekte neuer Imidazoacridinon-Antitumorsubstanzen Proliferation (DE-588)4047461-6 gnd Krebszelle (DE-588)4128704-6 gnd Acridinonderivate (DE-588)4141311-8 gnd Acridinon (DE-588)4141310-6 gnd Imidazolgruppe (DE-588)4161309-0 gnd Toxizität (DE-588)4078372-8 gnd Cytostatikum (DE-588)4068347-3 gnd Pharmakologie (DE-588)4045687-0 gnd |
| subject_GND | (DE-588)4047461-6 (DE-588)4128704-6 (DE-588)4141311-8 (DE-588)4141310-6 (DE-588)4161309-0 (DE-588)4078372-8 (DE-588)4068347-3 (DE-588)4045687-0 (DE-588)4113937-9 |
| title | Pharmakologische und toxikologische Aspekte neuer Imidazoacridinon-Antitumorsubstanzen |
| title_auth | Pharmakologische und toxikologische Aspekte neuer Imidazoacridinon-Antitumorsubstanzen |
| title_exact_search | Pharmakologische und toxikologische Aspekte neuer Imidazoacridinon-Antitumorsubstanzen |
| title_full | Pharmakologische und toxikologische Aspekte neuer Imidazoacridinon-Antitumorsubstanzen Birgit Berger |
| title_fullStr | Pharmakologische und toxikologische Aspekte neuer Imidazoacridinon-Antitumorsubstanzen Birgit Berger |
| title_full_unstemmed | Pharmakologische und toxikologische Aspekte neuer Imidazoacridinon-Antitumorsubstanzen Birgit Berger |
| title_short | Pharmakologische und toxikologische Aspekte neuer Imidazoacridinon-Antitumorsubstanzen |
| title_sort | pharmakologische und toxikologische aspekte neuer imidazoacridinon antitumorsubstanzen |
| topic | Proliferation (DE-588)4047461-6 gnd Krebszelle (DE-588)4128704-6 gnd Acridinonderivate (DE-588)4141311-8 gnd Acridinon (DE-588)4141310-6 gnd Imidazolgruppe (DE-588)4161309-0 gnd Toxizität (DE-588)4078372-8 gnd Cytostatikum (DE-588)4068347-3 gnd Pharmakologie (DE-588)4045687-0 gnd |
| topic_facet | Proliferation Krebszelle Acridinonderivate Acridinon Imidazolgruppe Toxizität Cytostatikum Pharmakologie Hochschulschrift |
| work_keys_str_mv | AT bergerbirgit pharmakologischeundtoxikologischeaspekteneuerimidazoacridinonantitumorsubstanzen |